S. Korea's Samsung Teams With Quintiles Of U.S. For Biomedicals
This article was originally published in PharmAsia News
Executive Summary
Samsung Group of South Korea said it is forming a joint venture with U.S.-based Quintiles Transnational to provide the electronics giant with an entry to the biomedical industry